Literature DB >> 1826875

Pulmonary hypertension associated with long-standing thrombocytosis.

C Rostagno1, D Prisco, R Abbate, L Poggesi.   

Abstract

A case of thromboembolic pulmonary hypertension associated with long-standing thrombocytosis is presented. In this patient we found a significant local pulmonary platelet activation and thrombin generation as indicated by the existence of a transpulmonary gradient for thromboxane A2, beta thromboglobulin and fibrinopeptide A. Prolonged heparin and acetylsalicylic acid treatment resulted in improvement of clinical and hemodynamic conditions. These findings support the usefulness of anticoagulating and antiaggregating therapy in selected cases of pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826875     DOI: 10.1378/chest.99.5.1303

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis.

Authors:  A Tabarroki; D J Lindner; V Visconte; L Zhang; H J Rogers; Y Parker; H K Duong; A Lichtin; M E Kalaycio; M A Sekeres; S E Mountantonakis; G A Heresi; R V Tiu
Journal:  Leukemia       Date:  2014-01-10       Impact factor: 11.528

2.  Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.

Authors:  Claudia R Morris; Hae-Young Kim; Felicia Trachtenberg; John Wood; Charles T Quinn; Nancy Sweeters; Janet L Kwiatkowski; Alexis A Thompson; Patricia J Giardina; Jeanne Boudreaux; Nancy F Olivieri; John B Porter; Ellis J Neufeld; Elliott P Vichinsky
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

3.  Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.

Authors:  Ranju Gupta; Sirisha Perumandla; Yelena Patsiornik; Selvanayagam Niranjan; Anju Ohri
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

4.  Cardiovascular Manifestations of Myeloproliferative Disorders: A Review of the Literature.

Authors:  Muhammad Wasif Saif; Umer Khan; Bernard R Greenberg
Journal:  Hosp Physician       Date:  1999-07

5.  Cardiac Complications of Myeloproliferative Disorders.

Authors:  Muhammad Wasif Saif; Umer Khan; Bernard R Greenberg
Journal:  Resid Staff Physician       Date:  2001-07

6.  Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.

Authors:  Vichai Atichartakarn; Khanchit Likittanasombat; Suporn Chuncharunee; Pakorn Chandanamattha; Surapon Worapongpaiboon; Pantep Angchaisuksiri; Katcharin Aryurachai
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

7.  Complement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice.

Authors:  Eileen M Bauer; Han Zheng; Suzy Comhair; Serpil Erzurum; Timothy R Billiar; Philip M Bauer
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

8.  A 53-year-old woman with thrombocytosis and pulmonary embolism.

Authors:  Eftychia Demerouti; Athanassios Manginas; Evangelos Leontiadis; Theodoros Hatzis; George Athanassopoulos; Konstantinos Mihas; Gregory Pavlides
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

9.  Post splenectomy related pulmonary hypertension.

Authors:  Atul V Palkar; Abhinav Agrawal; Sameer Verma; Asma Iftikhar; Edmund J Miller; Arunabh Talwar
Journal:  World J Respirol       Date:  2015-07-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.